While initially a concern, the rate of pancreatitis does not appear to be significantly increased by GLP-1RA based on a pooled analysis of 33,457 patients enrolled in cardiovascular outcome trials [184]
The therapeutic limitations of the use of sulforaphane in cancer are represented by the complete lack of knowledge of the potential anticancer effects at the cellular level and the effects on the immune system, the lack of translational studies to establish the effective doses in humans, and the interactions with conventional chemotherapy medication
Lo que dice Marcela es correcto, aunado a eso quiero hacerte incapie en que el efecto de levocarnitina es variable segn los pacientes, la dosis, y la deficiencia que presenten
10.1007/s00405-016-4378-6 68 World Health Organization
In particular, tell your provider if you have or had a past history of: Type 1 or type 2 diabetes Thyroid cancer Gastrointestinal disease Pancreatitis Kidney disease Diabetic retinopathy Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding
